Prediction of pathological complete response after neoadjuvant chemotherapy for HER2-negative breast cancer patients with routine immunohistochemical markers

Pathological complete response (pCR) is an established surrogate marker for prognosis in patients with breast cancer (BC) after neoadjuvant chemotherapy. Individualized pCR prediction based on clinical information available at biopsy, particularly immunohistochemical (IHC) markers, may help identify...

Full description

Bibliographic Details

Main Authors:	Häberle, Lothar (Author) , Erber, Ramona (Author) , Gass, Paul (Author) , Hein, Alexander (Author) , Niklos, Melitta (Author) , Volz, Bernhard (Author) , Hack, Carolin C. (Author) , Schulz-Wendtland, Rüdiger (Author) , Huebner, Hanna (Author) , Goossens, Chloë (Author) , Christgen, Matthias (Author) , Dörk, Thilo (Author) , Park-Simon, Tjoung-Won (Author) , Schneeweiss, Andreas (Author) , Untch, Michael (Author) , Nekljudova, Valentina (Author) , Loibl, Sibylle (Author) , Hartmann, Arndt (Author) , Beckmann, Matthias W. (Author) , Fasching, Peter A. (Author)
Format:	Article (Journal)
Language:	English
Published:	24 January 2025
In:	Breast cancer research Year: 2025, Volume: 27, Pages: 1-13
ISSN:	1465-542X
DOI:	10.1186/s13058-025-01960-8
Online Access:	Verlag, kostenfrei, Volltext: https://doi.org/10.1186/s13058-025-01960-8 Verlag, kostenfrei, Volltext: https://breast-cancer-research.biomedcentral.com/articles/10.1186/s13058-025-01960-8
Author Notes:	Lothar Häberle, Ramona Erber, Paul Gass, Alexander Hein, Melitta Niklos, Bernhard Volz, Carolin C. Hack, Rüdiger Schulz-Wendtland, Hanna Huebner, Chloë Goossens, Matthias Christgen, Thilo Dörk, Tjoung-Won Park-Simon, Andreas Schneeweiss, Michael Untch, Valentina Nekljudova, Sibylle Loibl, Arndt Hartmann, Matthias W. Beckmann and Peter A. Fasching